Search Results 261-270 of 16290 for VEO-IBD

  1. Medical Research & Education - Mayo Clinic News Network

    What is inflammatory bowel disease? Jennifer O'Hara. April 25, 2019. Majority of U.S. states restrict ...

  2. Medical Research & Education - Mayo Clinic News Network

    Such[...] Latest stories. Inflammatory Bowel Disease Diagnoses Rising featured image.

  3. Gastroenterology and Hepatology - Clinical trials

    Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...

  4. A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection - Mayo Clinic

    ... inflammatory bowel disease (IBD), Crohn's Disease, or ulcerative colitis. Note: This does not apply to previous surgery such as hernia repair unrelated to IBD.

  5. Clinical trials - Oncology (Medical)

    To evaluate the incidence of immune checkpoint inhibitors (ICI)-induced colitis (IIC) in patients with solid malignancies receiving over-the-counter multi- ...

  6. Medical Research & Education - Mayo Clinic News Network

    Is a hepatitis B immunity check needed for IBD patients? Katie Helwig. May 4, 2023. Leading scientists share advances in Omics- ...

  7. Gastroenterology and Hepatology - Clinical trials

    Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...

  8. Medical Research & Education - Mayo Clinic News Network

    Cancer. #MayoClinicRadio podcast: 1/12/19. Jennifer O'Hara. January 14, 2019. Research. Microbiome Role in Cancer, IBD, Obesity, and Infections. Mayo Clinic ...

  9. Medical Research & Education - Mayo Clinic News Network

    Microbiome Role in Cancer, IBD, Obesity, and Infections. Mayo Clinic Staff. January 14, 2019. Discovery Science. Recruiting Microbes to Fight Autoimmune ...

  10. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    fulminant colitis,; toxic megacolon;; or any other manifestation that might require surgery while enrolled in the study;; Subject with ostomy or ileoanal pouch ...